0001161697-22-000399.txt : 20220819
0001161697-22-000399.hdr.sgml : 20220819
20220819170254
ACCESSION NUMBER: 0001161697-22-000399
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220818
FILED AS OF DATE: 20220819
DATE AS OF CHANGE: 20220819
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCENANY PATRICK J
CENTRAL INDEX KEY: 0000929985
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 221181503
MAIL ADDRESS:
STREET 1: C/O THERMOGENESIS CORP
STREET 2: 2711 CITRUS ROAD
CITY: RANCHO CORDOVA
STATE: CA
ZIP: 95742
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form4.xml
FORM 4 FOR 08-18-2022
X0306
4
2022-08-18
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0000929985
MCENANY PATRICK J
355 ALHAMBRA CIRCLE, SUITE 801
CORAL GABLES
FL
33134
1
1
0
0
President and CEO
Common stock, par value $0.001 per share
2022-08-18
4
M
0
25000
2.53
A
4955217
D
Common stock, par value $0.001 per share
2022-08-18
4
S
0
25000
13.934
D
4930217
D
Common stock, par value $0.001 per share
2022-08-18
4
M
0
50000
2.53
A
4980217
D
Common stock, par value $0.001 per share
2022-08-18
4
S
0
50000
13.930
D
4930217
D
Common Stock, par value $0.001 per share
2022-08-18
4
M
0
50000
2.53
A
4980217
D
Common stock, par value $0.001 per share
2022-08-18
4
S
0
50000
13.959
D
4930217
D
Common stock,. par value $0.001 per share
2022-08-18
4
M
0
50000
2.53
A
4980217
D
Common stock, par value $0.001 per share
2022-08-18
4
S
0
50000
13.951
D
4930217
D
Common stock, par value $0.001 per share
2022-08-19
4
M
0
125000
2.53
A
5055217
D
Common stock, par value $0.001 per share
2022-08-19
4
S
0
125000
14.0994
D
4930217
D
Options to purchase common stock
2.53
2022-08-18
4
M
0
25000
0
D
2022-12-30
Common Stock
25000
3640834
D
Options to purchase common stock
2.53
2022-08-18
4
M
0
50000
0
D
2022-12-30
Common Stock
50000
3590834
D
Options to purchase common stock
2.53
2022-08-18
4
M
0
50000
0
D
2022-12-30
Common Stock
50000
3540834
D
Options to purchase common stock
2.53
2022-08-18
4
M
0
50000
0
D
2022-12-30
Common Stock
50000
3490834
D
Options to purchase common stock
2.53
2022-08-19
4
M
0
125000
0
D
2022-12-30
Common Stock
125000
3365834
D
Shares were sold in various lots from $13.93 to $13.97 per share. The listed sales price represents a weighted average price for the shares sold.
Shares were sold in various lots from $13.93 to $13.94 per share. The listed sales price represents a weighted average price for the shares sold.
Shares were sold in various lots from $13.95 to $14.00 per share. The listed sales price represents a weighted average price for the shares sold.
Shares were sold in various lots from $13.95 to $13.98 per share. The listed sales price represents a weighted average price for the shares sold.
Shares were sold in various lots from $14.05 to $14.14 per share. The listed sales price represents a weighted average price for the shares sold.
Shares were sold to cover the exercise price of options, tax withholding requirements (if applicable) and for personal reasons. The shares were not sold as a result of any agreement with the Company and Mr. McEnany remains an officer of the company.
Options vested in three separate tranches beginning on December 30, 2016.
/s/ Patrick J. McEnany
2022-08-19